Improved FAP-radiotheranostics for personalized cancer treatment Cancer-associated fibroblasts (CAFs) are a group of tumor stromal cells typically associated with cancer growth and metastasis. These CAFs show high expression of the fibroblast activation protein (FAP) on the cell membrane. Due to the selective FAP expression and cancer-specific distribution, CAFs have emerged as a promising cancer diagnostic marker and an attractive therapeutic target.

Louis Lauwerys a PhD student from CREANT has won a poster award at the European Molecular Imaging Meeting (EMIM) in Salzburg (Austria) for his work on the design and evaluation of a novel caspase-3 radiotracer for monitoring apoptosis in response to cancer therapy. Congratulations Louis!

We currently do not have open vacancies. However, you can make an open application for the role you want at any time by contacting us.